Adrenal incidentaloma: case report and synthesis of indication and thresholds of surgery therapy

被引:0
作者
Frazzetta, M. [1 ]
Tornambe, A. [1 ]
Barrera, T. [1 ]
Sciortino, A. [1 ]
Lucania, M. [1 ]
Frazzetta, F. [1 ]
Sammartano, A. [1 ]
Bonventre, S. [1 ]
Vetri, R. [1 ]
机构
[1] Univ Palermo, Policlin Paolo Giaccone, Dipartimento Discipline Chirurg & Oncol, Palermo, Italy
来源
GIORNALE DI CHIRURGIA | 2010年 / 31卷 / 11-12期
关键词
Incidentaloma; Adrenal gland; Pheochromocytoma;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
With the term of incidental mass, any mass is identified, occasionally discovered with imaging techniques, in the absence of specific symptoms. In 1982, the term "incidentaloma" was introduced to indicate lesions detected on adrenal regions, found unexpectedly. The incidence percentages vary from 0.6%-3% in CT followed by other indications, to 10% and 25% in all patients who underwent an ultrasound, CT or MRI. An appropriate diagnostic protocol is mandatory to identify and to choose the proper treatment for the functioning lesions, as well as the malignant or potentially malignant lesions (1, 2). Incidentalomas with diameters under 1 cm seem to not have a pathologic significance, and are considered like manifestation of the gland involution in advancedage subjects, and can remain unseen for a long time. The use of diagnostic imaging techniques has made it possible to identify these masses, even those of small size, in the course of diagnostic surveys done under various guidelines. The mass dimensions are a fundamental parameter used to distinguish benign lesions from malign ones (2, 3). Most Authors suspect malignity in masses above 5-6 cm, while considering those with a diameter under 3 cm to be benign. Whereas the rest remain undefined, thereby valued and treated according to criteria not perfectly established.
引用
收藏
页码:534 / 536
页数:3
相关论文
共 7 条
  • [1] [Anonymous], 2008, CASE ADRENAL INCIDE, V99, P150
  • [2] Editorial: Biochemical diagnosis of pheochromocytoma - Is it time to switch to plasma-free metanephrines?
    Eisenhofer, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02) : 550 - 552
  • [3] Lenz Tomas, 2002, Clin Lab, V48, P5
  • [4] Imaging vs biochemical testing for pheochromocytoma
    Neumann, HPH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03): : 314 - 315
  • [5] Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
    Pacak, K
    Linehan, WM
    Eisenhofer, G
    Walther, MM
    Goldstein, DS
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (04) : 315 - 329
  • [6] PROYE C, 1988, ANN CHIR, V42, P3
  • [7] Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma
    Raber, W
    Raffesberg, W
    Bischof, M
    Scheuba, C
    Niederle, B
    Gasic, S
    Waldhäusl, W
    Roden, M
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) : 2957 - 2963